CLINICAL NEWS

AAP updates ADHD guidelines in younger children and adolescents

The AAP recently issued updated guidelines to help diagnose and treat ADHD in younger children and adolescents. » More

Folic acid use in early pregnancy may reduce risk of language delay

Use of folic acid supplements in early pregnancy appeared to reduce the risk of severe language delay in children at age 3 years, according to the results of a study published October 12 in the Journal of the American Medical Association. » More

RTS,S/AS01 vaccine provides protection against clinical, severe malaria in African children, study shows

The first results from an ongoing phase 3 trial of RTS,S/AS01 show it provides African children with significant protection against clinical and severe malaria. The results were published online October 18 in the New England Journal of Medicine. » More

FDA ACTIONS

FDA hears first reactions to the PDUFA V proposal

FDA sounded the opening bell on October 24 in what is likely to be a brawl among health groups over upgrading FDA drug approval and post-marketing authorities under the PDUFA V proposal. » More

PAIN MANAGEMENT

Prescription nasal spray for breakthrough pain management in cancer patients is now available in the U.S.

Fentanyl (Lazanda, Archimedes Pharma U.S. Inc.), a new prescription nasal spray for managing pain in cancer patients, launched in the United States this month. » More

HOSPITAL READMISSIONS

Improvement needed for risk prediction models for hospital readmission

Most current hospital readmission risk prediction models that were designed for either comparative or clinical purposes perform poorly. The findings were reported in the October 19 issue of the Journal of the American Medical Association. » More

FOUNDATION NEWS

ASHP Foundation will hold webinars, Research Boot Camp in November

The ASHP Foundation is holding webinars and a “Research Boot Camp” that will help researchers obtain grants from the organization. » More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

•	Anticoagulation update
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.